CDC data reveal that infant #RSV #immunization strategies significantly reduce medically attended pediatric illness. #IDTwitter
Nirsevimab and Maternal RSV Vaccination Prevent Severe Pediatric Outcomes
Real-world data demonstrate that nirsevimab and maternal vaccination protect infants against severe RSV outcomes.
www.infectiousdiseaseadvisor.com
September 28, 2026 at 7:44 PM
CDC data reveal that infant #RSV #immunization strategies significantly reduce medically attended pediatric illness. #IDTwitter
【交換✧︎譲渡】あんスタ カードダス vol.2
求︰R宗、N宗＞Rみか、Nみか
譲︰画像参照
✧︎R⇔R、N⇔N、R1⇔N2
✧︎N日和、茨、ジュンはN宗との交換優先。
✧︎Rアドニス・維吹、Nエスお声がけ中
IDTwitterのです。
お声がけは、ブルスカでも、Twitterにでもどちらでも大丈夫です🙌
求︰R宗、N宗＞Rみか、Nみか
譲︰画像参照
✧︎R⇔R、N⇔N、R1⇔N2
✧︎N日和、茨、ジュンはN宗との交換優先。
✧︎Rアドニス・維吹、Nエスお声がけ中
IDTwitterのです。
お声がけは、ブルスカでも、Twitterにでもどちらでも大丈夫です🙌
September 21, 2026 at 11:08 AM
【交換✧︎譲渡】あんスタ カードダス vol.2
求︰R宗、N宗＞Rみか、Nみか
譲︰画像参照
✧︎R⇔R、N⇔N、R1⇔N2
✧︎N日和、茨、ジュンはN宗との交換優先。
✧︎Rアドニス・維吹、Nエスお声がけ中
IDTwitterのです。
お声がけは、ブルスカでも、Twitterにでもどちらでも大丈夫です🙌
求︰R宗、N宗＞Rみか、Nみか
譲︰画像参照
✧︎R⇔R、N⇔N、R1⇔N2
✧︎N日和、茨、ジュンはN宗との交換優先。
✧︎Rアドニス・維吹、Nエスお声がけ中
IDTwitterのです。
お声がけは、ブルスカでも、Twitterにでもどちらでも大丈夫です🙌
Surgical antibiotic prophylaxis through the ALARA lens: Data from England
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4y5yxkh
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4y5yxkh
September 20, 2026 at 8:29 PM
Surgical antibiotic prophylaxis through the ALARA lens: Data from England
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4y5yxkh
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4y5yxkh
Cytomegalovirus Immune Responses and Cognitive Impairment in People With Human Immunodeficiency Virus
🔁 Repost
#IDTwitter
🔗 https://t.co/FVQtwGhRTW
🔁 Repost
#IDTwitter
🔗 https://t.co/FVQtwGhRTW
September 18, 2026 at 10:08 PM
Cytomegalovirus Immune Responses and Cognitive Impairment in People With Human Immunodeficiency Virus
🔁 Repost
#IDTwitter
🔗 https://t.co/FVQtwGhRTW
🔁 Repost
#IDTwitter
🔗 https://t.co/FVQtwGhRTW
Absolutely !! Also, @josephmarcusid.medsky.social is organizing an IDTwitter meet up!!
September 17, 2026 at 3:07 AM
Absolutely !! Also, @josephmarcusid.medsky.social is organizing an IDTwitter meet up!!
#Cefepime and mortality: Is cefepime completely safe?
A Bayesian meta-analysis of 110 RCTs (22,608 patients) found a 94.4% posterior probability of higher mortality vs other β-lactams.
An important signal—but not a reason to abandon cefepime.
DOI: 10.1001/jamanetworkopen.2026.33017#IDTwitter
A Bayesian meta-analysis of 110 RCTs (22,608 patients) found a 94.4% posterior probability of higher mortality vs other β-lactams.
An important signal—but not a reason to abandon cefepime.
DOI: 10.1001/jamanetworkopen.2026.33017#IDTwitter
September 16, 2026 at 6:31 AM
#Cefepime and mortality: Is cefepime completely safe?
A Bayesian meta-analysis of 110 RCTs (22,608 patients) found a 94.4% posterior probability of higher mortality vs other β-lactams.
An important signal—but not a reason to abandon cefepime.
DOI: 10.1001/jamanetworkopen.2026.33017#IDTwitter
A Bayesian meta-analysis of 110 RCTs (22,608 patients) found a 94.4% posterior probability of higher mortality vs other β-lactams.
An important signal—but not a reason to abandon cefepime.
DOI: 10.1001/jamanetworkopen.2026.33017#IDTwitter
I miss the chatter and engagement of #IDTwitter and I realise I should be more active!! Here’s my attempt: who’s actually going to be at #IDWeek @idweek.bsky.social ??
September 16, 2026 at 2:17 AM
I miss the chatter and engagement of #IDTwitter and I realise I should be more active!! Here’s my attempt: who’s actually going to be at #IDWeek @idweek.bsky.social ??
Time to Antibiotics or Time to Effective Antimicrobial Therapy?
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4xlrv9S
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4xlrv9S
September 14, 2026 at 1:10 AM
Time to Antibiotics or Time to Effective Antimicrobial Therapy?
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4xlrv9S
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4xlrv9S
The Power of Public Science: Lessons From TV003 and Butantan-DV
🔁 Repost
#IDTwitter
🔗 https://t.co/cBXhl9LFRL
🔁 Repost
#IDTwitter
🔗 https://t.co/cBXhl9LFRL
September 2, 2026 at 11:12 PM
The Power of Public Science: Lessons From TV003 and Butantan-DV
🔁 Repost
#IDTwitter
🔗 https://t.co/cBXhl9LFRL
🔁 Repost
#IDTwitter
🔗 https://t.co/cBXhl9LFRL
Response to concerns of generalizability of the BeBoP trial
🔁 Repost
#IDTwitter
🔗 https://t.co/i7cjRQVwIh
🔁 Repost
#IDTwitter
🔗 https://t.co/i7cjRQVwIh
August 22, 2026 at 10:20 PM
Response to concerns of generalizability of the BeBoP trial
🔁 Repost
#IDTwitter
🔗 https://t.co/i7cjRQVwIh
🔁 Repost
#IDTwitter
🔗 https://t.co/i7cjRQVwIh
Are we still giving antibiotics for too long? 💊⏱️
Evidence for shorter courses continues to grow. So how short is too short?
🔗: https://shmpublications.onlinelibrary.wiley.com/doi/10.1002/jhm.70218
✍️: @WAaronManning, @MattMil81732351
🖼️: Catie Glatz
#SHM #JHM #MedED #IDTwitter
Evidence for shorter courses continues to grow. So how short is too short?
🔗: https://shmpublications.onlinelibrary.wiley.com/doi/10.1002/jhm.70218
✍️: @WAaronManning, @MattMil81732351
🖼️: Catie Glatz
#SHM #JHM #MedED #IDTwitter
August 22, 2026 at 7:49 PM
Are we still giving antibiotics for too long? 💊⏱️
Evidence for shorter courses continues to grow. So how short is too short?
🔗: https://shmpublications.onlinelibrary.wiley.com/doi/10.1002/jhm.70218
✍️: @WAaronManning, @MattMil81732351
🖼️: Catie Glatz
#SHM #JHM #MedED #IDTwitter
Evidence for shorter courses continues to grow. So how short is too short?
🔗: https://shmpublications.onlinelibrary.wiley.com/doi/10.1002/jhm.70218
✍️: @WAaronManning, @MattMil81732351
🖼️: Catie Glatz
#SHM #JHM #MedED #IDTwitter
Development and Application of an Anaerobic Activity Index
🔁 Repost
#IDTwitter
🔗 https://t.co/h7xJ4uLQWn
🔁 Repost
#IDTwitter
🔗 https://t.co/h7xJ4uLQWn
August 21, 2026 at 8:46 PM
Development and Application of an Anaerobic Activity Index
🔁 Repost
#IDTwitter
🔗 https://t.co/h7xJ4uLQWn
🔁 Repost
#IDTwitter
🔗 https://t.co/h7xJ4uLQWn
August 19, 2026 at 8:37 PM
🚨 BALANCE trial sub-study results
Anti-anaerobic ABX in pts with BSI w/o indication for anaerobic coverage were associated with a higher 90-day mortality and gut microbiome disruption.
Read more: doi.org/10.1093/cid/...
#IDXposts #IDtwitter
Anti-anaerobic ABX in pts with BSI w/o indication for anaerobic coverage were associated with a higher 90-day mortality and gut microbiome disruption.
Read more: doi.org/10.1093/cid/...
#IDXposts #IDtwitter
Association of anti-anaerobic antibiotics with mortality and the gut microbiome: a sub-study of the BALANCE randomized clinical trial
AbstractBackground. Patients with suspected bloodstream infection often receive broad-spectrum antibiotics with anaerobic activity in the absence of clinic
doi.org
August 14, 2026 at 4:01 PM
🚨 BALANCE trial sub-study results
Anti-anaerobic ABX in pts with BSI w/o indication for anaerobic coverage were associated with a higher 90-day mortality and gut microbiome disruption.
Read more: doi.org/10.1093/cid/...
#IDXposts #IDtwitter
Anti-anaerobic ABX in pts with BSI w/o indication for anaerobic coverage were associated with a higher 90-day mortality and gut microbiome disruption.
Read more: doi.org/10.1093/cid/...
#IDXposts #IDtwitter
Bacteriophage therapy of Mycobacterium abscessus mastoiditis
🔁 Repost
#IDTwitter
🔗 https://t.co/m8Gwrw9XS7
🔁 Repost
#IDTwitter
🔗 https://t.co/m8Gwrw9XS7
August 14, 2026 at 1:55 AM
Bacteriophage therapy of Mycobacterium abscessus mastoiditis
🔁 Repost
#IDTwitter
🔗 https://t.co/m8Gwrw9XS7
🔁 Repost
#IDTwitter
🔗 https://t.co/m8Gwrw9XS7
Identification of invasive aspergillosis in electronic health records
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/3S2g08U
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/3S2g08U
August 13, 2026 at 3:49 AM
Identification of invasive aspergillosis in electronic health records
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/3S2g08U
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/3S2g08U
🚨 New PO step-down data 🚨
This retrospective study determined that PO cefadroxil stepdown therapy has similar treatment success compared to IV ABX and alternative PO ABX for pts w/ lower-risk MSSA/strep BSI.
🤔 What are your thoughts? #IDTwitter academic.oup.com/ofid/article...
This retrospective study determined that PO cefadroxil stepdown therapy has similar treatment success compared to IV ABX and alternative PO ABX for pts w/ lower-risk MSSA/strep BSI.
🤔 What are your thoughts? #IDTwitter academic.oup.com/ofid/article...
Cefadroxil as Oral Transitional Therapy for Gram-Positive Bacteremia With or Without Non-Vertebral Osteomyelitis: A Multicenter Retrospective Cohort Study
In this multicenter, retrospective cohort study, cefadroxil was an effective and safe oral transitional therapy for bloodstream infections, with or without
academic.oup.com
August 12, 2026 at 4:52 PM
🚨 New PO step-down data 🚨
This retrospective study determined that PO cefadroxil stepdown therapy has similar treatment success compared to IV ABX and alternative PO ABX for pts w/ lower-risk MSSA/strep BSI.
🤔 What are your thoughts? #IDTwitter academic.oup.com/ofid/article...
This retrospective study determined that PO cefadroxil stepdown therapy has similar treatment success compared to IV ABX and alternative PO ABX for pts w/ lower-risk MSSA/strep BSI.
🤔 What are your thoughts? #IDTwitter academic.oup.com/ofid/article...
Crisis as Catalyst: The Future of the NIH Driving Scientific Discovery
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4xjj27q
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4xjj27q
August 7, 2026 at 9:31 PM
Crisis as Catalyst: The Future of the NIH Driving Scientific Discovery
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4xjj27q
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4xjj27q
The Power of Public Science: Lessons From TV003 and Butantan-DV
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4fWJ9tQ
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4fWJ9tQ
August 6, 2026 at 9:17 PM
The Power of Public Science: Lessons From TV003 and Butantan-DV
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4fWJ9tQ
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4fWJ9tQ
Development and Application of an Anaerobic Activity Index
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4w2Venj
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4w2Venj
August 5, 2026 at 8:33 PM
Development and Application of an Anaerobic Activity Index
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4w2Venj
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4w2Venj
August 1, 2026 at 3:46 AM
Valve strands: to be or not to be… infective endocarditis?
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4pOE4sg
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4pOE4sg
July 31, 2026 at 2:50 AM
Valve strands: to be or not to be… infective endocarditis?
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4pOE4sg
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4pOE4sg
A good reminder that effective stewardship messaging requires evidence. 📖 academic.oup.com/cid... #IDTwitter #AntimicrobialStewardship
July 27, 2026 at 12:58 PM
A good reminder that effective stewardship messaging requires evidence. 📖 academic.oup.com/cid... #IDTwitter #AntimicrobialStewardship
Bacteriophage therapy of Mycobacterium abscessus mastoiditis
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4c1VgVg
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4c1VgVg
July 26, 2026 at 3:05 AM
Bacteriophage therapy of Mycobacterium abscessus mastoiditis
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4c1VgVg
✅ Just Accepted
#IDTwitter
🔗 https://bit.ly/4c1VgVg
🗓️ Save the Date! We're thrilled to welcome Dr. Brad Spellberg to IDSG on September 30! Join us at 6:30 PM at Atlanta Fish Market for what promises to be a fantastic discussion on IV→PO conversion, duration of therapy, antimicrobial stewardship, and more. Stay tuned! #IDSG #IDTwitter #AMS
July 24, 2026 at 3:58 PM
🗓️ Save the Date! We're thrilled to welcome Dr. Brad Spellberg to IDSG on September 30! Join us at 6:30 PM at Atlanta Fish Market for what promises to be a fantastic discussion on IV→PO conversion, duration of therapy, antimicrobial stewardship, and more. Stay tuned! #IDSG #IDTwitter #AMS